Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2012 Results
Date:11/7/2012

WASHINGTON, Nov. 7, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the third quarter and nine months ended September 30, 2012.

Key Highlights:

  • The tasimelteon Non-24-Hour Disorder (Non-24) program continues towards the goal of a projected mid-2013 New Drug Application (NDA) filing with the U.S. Food and Drug Administration (FDA). 
  • The SET and RESET Phase III efficacy studies for Non-24 are both fully enrolled.  Vanda expects to report top-line results for the SET study by the end of 2012 and to report top-line results for the RESET study in the first quarter of 2013.
  • The tasimelteon MAGELLAN Phase IIb/III efficacy study for Major Depressive Disorder (MDD) is fully enrolled and Vanda expects to report top-line results in the first quarter of 2013.
  • Vanda recorded third quarter 2012 revenue of $8.3 million including Fanapt® royalties of $1.5 million.  Fanapt® prescriptions, as reported by IMS, were approximately 38,500 for the third quarter of 2012.  This represents a 3% increase over second quarter 2012 prescriptions and a 15% increase over third quarter 2011 prescriptions.

    • THIRD QUARTER 2012 REPORTED RESULTS
    Total revenues for the third quarter of 2012 were $8.3 million, compared to $8.0 million for the same period in 2011.  Third quarter 2012 revenues included $1.5 million in Fanapt® royalties received from Novartis as compared to royalties of $1.2 million for the third quarter of 2011.Total operating expenses for the third quarter of 2012 were $13.7 million, compared to $11.3 million for the third quarter of 2011.  The higher expen
    '/>"/>

    SOURCE Vanda Pharmaceuticals Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
    2. Vanda Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 2, 2012
    3. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
    4. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
    5. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
    6. Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference
    7. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
    8. Vanda Pharmaceuticals Reports First Quarter 2012 Results
    9. Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe
    10. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
    11. Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2013)...  Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a ... that Dr. Robert Grieve , the Company,s ... , executive vice president and chief financial officer, will ... being held May 30, 2013 in New York ... The Company,s presentation is scheduled to begin at 1:30 ...
    (Date:5/24/2013)... 24, 2013  Sinovac Biotech Ltd. (NASDAQ: ... products in China , announced ... of Sinovac, obtained the Certificate of Good Manufacturing ... China State and Food Administration (CFDA) for its ... and its Changping filing and packaging facility. The ...
    (Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...
    Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
    ... -,Phytopharm plc (LSE: PYM) ("Phytopharm" or the ... reverses the,changes in the area of the ... be presented by Dr Jonathan Brotchie, an,internationally ... International Congress of Parkinson's Disease and Movement,Disorders' ...
    ... the Companies' Novel Heat Shock Protein 90 ... Biological,Activity , CAMBRIDGE, Mass. and GAITHERSBURG, Md., ... Inc. (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) today announced ... trial of the companies' heat shock,protein 90 ...
    Cached Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7
    (Date:5/25/2013)... According to a new market ... published by MarketsandMarkets is expected to reach $544.02 ... which analyzes and studies the major market drivers, ... and Rest of the World. , Browse:, ... 87 Figures , 175 ...
    (Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...
    (Date:5/25/2013)... Los Angeles, CA (PRWEB) May 25, 2013 ... will grow at an average annual rate of 28.7% ... growth of 17.9% in 2013. From 2002 and 2008, no ... analyst Kevin Culbert, causing relatively modest growth during that period. ... (FDA) has approved six new products. This factor contributed to ...
    (Date:5/25/2013)... 25, 2013 Ayurveda is the ... wisdom of life". While a medical science, its scope enters ... consciousness. Its fundamental philosophy is that disease is the end ... order to re-establish optimal health, one must discover where we ... style which brings us back into perfect harmony. , The ...
    (Date:5/25/2013)... Flagstaff, Arizona (PRWEB) May 25, 2013 The ... Rehabilitation Center, their parents, and the B2B staff all came ... While everyone enjoyed an array of Indian Cuisine, the residents ... the company, for helping them on their road to recovery, ... started the Drug and Alcohol center in 2010 after realizing ...
    Breaking Medicine News(10 mins):Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
    ... , WEDNESDAY, Nov. 2 (HealthDay News) -- A new drug ... to improved lung function and fewer symptoms in people with ... -- is the first to halt the underlying processes that ... build up in the lungs and the pancreas and can ...
    ... WEDNESDAY, Nov. 2 (HealthDay News) -- The death toll in ... farm has reached 29, with another 139 people sickened in ... recently that the outbreak appeared to have been caused by ... Sept. 22 and 23 by federal and state authorities at ...
    ... not effectively prepare firefighters for the range of ... human factors/ergonomics researchers Michael R. Baumann, Carol L. ... 2011 Human Factors article, "Phased Training ... the authors assess the value of current scenario-based ...
    ... , WEDNESDAY, Nov. 2 (HealthDay News) -- Researchers using ... far determined that it was a child of a wealthy ... The mummy, owned by the Spurlock Museum at ... 1990, and more scans with updated CT technology this year. ...
    ... (HealthDay News) -- The legalization of medical marijuana in ... the availability and appeal of the drug among youth, ... the study, Rhode Island Hospital researchers examined adolescent marijuana ... 2009. Rhode Island legalized medical marijuana in 2006. ...
    ... from the University of Notre Dame,s Keck Center ... are joining forces to use a new medical ... patients.Researchers at the Keck Center investigate how the ... inflammatory diseases like sepsis, atherosclerosis and asthma. In ...
    Cached Medicine News:Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 2Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 3Health News:New Drug Targets Underlying Cause of Cystic Fibrosis 4Health News:Death Toll From Listeria Outbreak Hits 29 2Health News:Death Toll From Listeria Outbreak Hits 29 3Health News:Current training programs may not prepare firefighters to combat stress 2Health News:Modern Technology Reveals Clues From Egyptian Mummy 2Health News:Univesity of Notre Dame researchers form new partnership to help trauma patients 2
    High sensitive, specific one step immunochromatographic assay for human infectious disease...
    Span Diagnostics Limited...
    Malaria (P. fal.) Ag Rapid Test...
    OptiMAL is a malaria test, for diagnosis and therapy control of an infection by Plasmodium species (Malaria)....
    Medicine Products: